Beximco Pharmaceuticals Ltd. GDR Stock
There is an upward development for Beximco Pharmaceuticals Ltd. GDR compared to yesterday, with an increase of €0.010 (2.130%).
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 2.130% | 5.727% | 6.667% | 16.505% | 15.385% | -20.661% | -46.961% |
| SELLAS Life Sciences Group Inc | 3.130% | 15.600% | 41.436% | 108.163% | 84.272% | -23.376% | -68.404% |
| Eledon Pharmaceuticals Inc. | -4.730% | 6.015% | -4.082% | -65.777% | -65.441% | -38.696% | -91.242% |
| Check Cap Ltd | 15.040% | 7.746% | 6.993% | 163.793% | 47.115% | -43.323% | 470.896% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%